Last reviewed · How we verify
Regular nasal air
At a glance
| Generic name | Regular nasal air |
|---|---|
| Sponsor | Region Skane |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Caracterization of the Combined Alterations in Respiration and aROUSal in Patients With Drug-resistant EpiLepsy (NA)
- Highlanders With High Altitude Pulmonary Hypertension (HAPH), 6 Minute Walk Distance (6MWD) Assessed at 3200m With and Without Supplemental Oxygen Therapy (SOT) (NA)
- Nasal High-Flow in COPD (NA)
- Comparative Effects of Blow Bottle and Acapella Along With Diaphragmatic Breathing in Patients With Pneumonia (NA)
- The Role of the Device Operating Under the Continuous Positive Airway Pressure in the Recovery Process of Cochlea (NA)
- Breathing for Adolescent Stress Reduction Feasibility RCT (NA)
- Diaphragmatic Breathing Exercises and Pelvic Floor Retraining in Children With Dysfunctional Voiding (NA)
- IN Insulin in Type 1 Diabetes (T1D) Hypoglycemia Unawareness: Safety Only Phase (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Regular nasal air CI brief — competitive landscape report
- Regular nasal air updates RSS · CI watch RSS
- Region Skane portfolio CI